Mineralocorticoid Receptor Antagonists [MoA] class drugs

1 result
  • kerendia - finerenone tablet, film coated

    (Finerenone)
    Bayer Healthcare Pharmaceuticals Inc.
    Kerendia reduces risk of kidney disease progression, cardiovascular death, heart attack, and heart failure hospitalization in adults with chronic kidney disease and type 2 diabetes. Also indicated for cardiovascular death and heart failure events in adults with heart failure with preserved or mildly reduced ejection fraction (LVEF ≥ 40%).